J Clin Endocrinol Metab dgae722 Klonoff DC, Buse JB, Nielsen LL, Guan X, Bowlus CL, Holcombe JH et al (2008) Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years
More than half of patients experience minimal to no nausea, while only about a quarter experience significant nausea
2/ How GLP-1s help manage type 2 diabetes 3/ GLP-1 agonists and appetite 4/ How to amplify GLP-1 weight loss 5/ GLP-1s and food noise 6/ GLP-1s and heart and kidney health 7/ GLP-1s and mood 8/ GLP-1s and addiction 9/ GLP-1s and sleep 10/ GLP-1s and cancer 11/ The bottom line Its easy to miss the full story of GLP-1s
These prescriptions are often combined with lipotropic injections, nutrition support, and lifestyle coaching to enhance efficacy
Communicate with your doctor: If you consistently miss doses or are unsure what to do, contact your provider for guidance
The weekly injection is known as Sevmia from the Canadian company Apotex and is pharmaceutically equivalent to weight-loss medication Wegovy from Denmarks Novo Nordisk